MSB 8.42% $1.03 mesoblast limited

For investors waking up THERE IS NO NEWS YET, page-45

  1. 197 Posts.
    lightbulb Created with Sketch. 32
    in that case, that's certainly a good news for us.

    I thought there were three concerns flyby the FDA,

    manufacturing

    size of the trial

    Double blinded trial (which is out of questions due to high mortality)
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.